0 CHECKOUT

PRODUCT FILTERS

REGION

12
10
10
10
9

COUNTRY

10
1

CATEGORIES

  • 41
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

24
42
44
57

PUBLISHED

0
12
27
57

PRODUCT TYPE

22
15
10
7
1
1
1

Search for: "Titan Pharmaceuticals Inc.-Financial Company Report"

Titan Pharmaceuticals Inc. Company Profile - Business Description, Strategies, SWOT and Financial Analysis

“Titan Pharmaceuticals Inc. Company Profile” is a comprehensive report on Titan Pharmaceuticals Inc.. The report provides complete information on the operations, organization structure and financial...

Published:  October 2014
Price:  From

Titan Pharmaceuticals Inc. Company Profile - Business Strategies, Outlook Statement, Business Description, Products and Services, Competitors, Employees, Updates, SWOT and Financials

“Titan Pharmaceuticals Inc. Business Profile” is a comprehensive research on the company’s operations across the value chain. The report on Titan Pharmaceuticals Inc. analyzes the company’s key strategies,...

Published:  May 2016
Price:  From

Titan Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

The Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization...

Published:  March 2016
Price:  From

Titan Pharmaceuticals, Inc. - Product Pipeline Review - Q1 2011

Titan Pharmaceuticals, Inc. – Product Pipeline Review – Q1 2011 Summary Global Market Direct’s pharmaceuticals report, “Titan Pharmaceuticals, Inc. - Product Pipeline Review - Q1 2011” provides data...

Published:  May 2011
Price:  From

Titan Pharmaceuticals, Inc. - Product Pipeline Review - Q4 2010

Titan Pharmaceuticals, Inc. – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Titan Pharmaceuticals, Inc. - Product Pipeline Review - Q4 2010” provides data...

Published:  November 2010
Price:  From

Titan Pharmaceuticals, Inc. - Product Pipeline Review - Q4 2010

Titan Pharmaceuticals, Inc. – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Titan Pharmaceuticals, Inc. - Product Pipeline Review - Q4 2010” provides data...

Published:  November 2010
Price:  From

Contract Manufacturing in Pharmaceutical Industry, 2015-2025

Amongst the increasing financial pressures and the need to reduce cost and improve efficiencies, the pharmaceutical industry has witnessed a paradigm shift from vertically integrated business model...

Published:  February 2015
Price:  From

Titan Pharmaceuticals Inc

A textual analysis of the financial results for Titan Pharmaceuticals Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive...

Published:  July 2016
Price:  From

Alexza Pharmaceuticals, Inc. (ALXA) - Financial and Strategic SWOT Analysis Review

Alexza Pharmaceuticals, Inc. (ALXA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

Published:  December 2015
Price:  From

Alexza Pharmaceuticals, Inc. - Financial and Strategic SWOT Analysis Review

Alexza Pharmaceuticals, Inc. - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

Published:  July 2016
Price:  From

Plunkett's Biotech & Genetics Industry Almanac 2016: Biotech & Genetics Industry Market Research, Statistics, Trends & Leading Companies

Key Findings: - Plunkett Research lists top 400 companies in the Biotech & Genetics and names top trends changing the industry for the mid term. Key Features: - Industry trends analysis, market...

Published:  November 2015
Price:  From

Asterias Biotherapeutics Inc

A textual analysis of the financial results for Asterias Biotherapeutics Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive...

Published:  July 2016
Price: 

Lpath, Inc.

A textual analysis of the financial results for Lpath, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses...

Published:  July 2016
Price:  From

Market For Gene Therapy and Antisense Drugs

Once approved, gene therapy will completely supersede approaches to diseases that treat symptoms rather than affect a cure. The gene therapy market will grow quickly and is forecast to hit $3.2 billion...

Published:  August 1995
Price: 

North America Company Reports Database

The North America Company Reports Database consists of the full-text of interim, quarterly, annual and other reports from over 10,252 public companies listed on the major North American stock exchanges....

Published:  July 2016
Price:  From

Credit Trends: Bond Upgrade Potential In Emerging And Developed Markets, Including The U.S. And Europe: Potential Upgrades See Marginal Growth Sep 15

Abstract The number of potential bond upgrades increased to 262 as of Aug. 31, 2015, from 260 issuers as of July 27, 2015. A plurality (27) of the issuers are in the financial institutions sector,...

Published:  September 2015
Price: 

Telik, Inc. (TELK) - Financial and Strategic SWOT Analysis Review

Telik, Inc. (TELK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData...

Published:  June 2014
Price:  From

Biomarker Technology Platforms for Cancer Diagnoses and Therapies 2014

Until superior therapeutic treatments are developed to prevent, treat and cure cancer, the best means of reducing mortality and morbidity in a disease this complex is early detection and diagnosis....

Published:  July 2014
Price:  From

Affymetrix, Inc. (AFFX) - Financial and Strategic SWOT Analysis Review

Affymetrix, Inc. (AFFX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the...

Published:  March 2016
Price:  From

A Handful Of Countries Drive Corporate Issuer Growth In Emerging Markets, Says S&P Report Mar 16

Abstract NEW YORK (Standard & Poor's) March 15, 2016--Fixed income assets in the emerging markets have experienced significant growth over the years as economic development, and thus opportunities...

Published:  March 2016
Price: 
Loading Indicator

Our Clients

  • Hexcel Corporation
  • Harrods Ltd.
  • Bayer AG
  • Google, Inc.
  • Boeing Company
  • Harley Davidson Motor Company
  • SwissCom AG